39 results
8-K/A
EX-99.3
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
in connection with the closing of the Merger in accordance with Angion’s retention bonus plan.
Reclassification of $108.3 million to Additional Paid … )
Severance expenses related to Angion’s retention bonus plan (Note D)
Total pre-merger Angion’s accumulated deficit
Angion common stock
Angion accumulated
8-K
EX-99.3
646o0h
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
gzx2yta1
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
itwh2lkz
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
425
hpxuy5vzfyhk98cuc6s9
23 May 23
Business combination disclosure
8:42pm
8-K
63taagygpf05gp3i4
23 May 23
Other Events
8:40pm
424B3
x56zh7u wiig0ie0bk
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
en4q5tazs
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.26
kegr0oia3b ckwohi
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
xs9shm6u8omq8 fbjorv
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm